Bhagat Singh, Azad were terrorists, says UK historian

February 17, 2014

Bhagat_SinghSurat, Feb 17: A UK-based historian described Indian freedom fighters -- Bhagat Singh and Chandrashekhar Azad -- as "terrorists" during a lecture held here recently, sparking a controversy.

Delivering a lecture on 'Nonviolent Resistance In India during 1915-1947', Warwick University's professor David Hardiman said, "Terrorist groups, who predate Mahatma Gandhi, were always there alongside Gandhi's non-violent movement."

"Some of these famous figures were Bhagat Singh and Chandrashekhar Azad, who were involved in organisations like Hindustan Republic Association (HRA) and Hindustan Republic Socialist Association (HRSA)," the professor of United Kingdom's history said.

Speaking at the 24th I P Desai Memorial Lecture organised by Centre for Social Studies on February 14, Hardiman also said that Gandhi's movement was benefited due to other means of protests.

"Every non-violent movement has a violent group aiming to achieve the same ends with armed movement. The group often indulges in terror acts like bombings, shootings and assassinations. The non-violent movement was benefited because the authorities feel it is better to deal with them than the dangerous terrorists," Hardiman said.

Hardiman's remarks against the Indian revolutionaries angered the audience, who compelled him to clarify, following which, he said, "I did not use the word terrorists as a derogatory term."

Major Unmesh Pandya, member of executive council of Veer Narmad South Gujarat University, who was amongst the audience, stood up during the lecture and protested against Hardiman's remarks.

"The UK-based scholar used word terrorists seven to eight times for the revolutionaries. There is a unanimous understanding between the academicians of the entire world not to use the word terrorist for the people who had not killed innocent civilians. One can use words like extremist or revolutionary," Pandya said.

"A terrorist means who terrorises people. But freedom fighters like Bhagat Singh or Chandrashekhar Azad initiated armed movement against imperialism. If one considers any violent or armed movement as a terror activity, then under that definition British Raj or Queen Victoria's activities can also be defined as terrorism," he added.

Defending Hardiman, Professor Ghanshyam Shah, a political scientist and member of the Board of Governors of Centre for Social Studies, said his remarks should be taken in a different periodical contexts.

"The context is different. At that time, non-violent movement was going on and certain people chose another way, including Bhagat Singh, Azad, Shyamji Krishna Verma and Savarkar. They had difference of opinions with Gandhi's non-violent movement. In that sense, he (Hardiman) said Bhaghat Singh involved in a movement other than the non-violent movement.

"But he surely did not equate the revolutionaries with the present jihadi terrorists. Bhagat Singh himself believed in militancy based freedom movement, he chose that way. One has to analyse Hardiman's words in proper contexts," Shah said.

Condemning Hardiman's comment, human rights activists and a scholar of Bhagat Singh's works, Hiren Gandhi termed the remarks as "logical in the context of a Britisher".

"We believe he was a revolutionary, they (Britishers) believe he was a terrorist. That is very natural and logical for a Britisher. Bhagat Singh had done 79 days hunger strike that shows he also believed in non-violence and satyagraha. His ways might be different from the Gandhian ways, but then he cannot be described as a terrorists," said Gandhi.

Quoting Bhagat Singh from 'Collected works of Bhaghat Singh', Gandhi said, "To root out imperialism and its vested interests and to bring socialism, terror acts are necessary.

"Bhagat Singh believed that revolution does not mean change of power, but it also implies transformation of society. That transformation can be achieved after a long process, which includes violent and non-violent ways," Gandhi said quoting Bhagat Singh.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 9,2020

Kolkata, Mar 9: A diabetic man died in the isolation ward of a hospital in West Bengal's Murshidabad on Sunday, a day after he was admitted there with suspected symptoms of coronavirus following his return from Saudi Arabia.

According to doctors, he was admitted to the hospital with fever, cough and cold.

Though test results of his blood and swab samples for novel coronavirus were awaited, it can be said that he died probably of diabetes, Director of Health Services Ajay Chakraborty told PTI.

"The man was highly diabetic and was on insulin. He returned home from Saudi Arabia and had no money to take insulin for the last three to four days.

"He was also suffering from fever, cough and cold. He was admitted to the isolation ward of the Murshidabad Medical College and Hospital yesterday and died today," the health services director said.

"We are waiting for the results of medical tests. The possibility of his death due to novel coronavirus infection is remote," he said.

However, precautions will be taken during the last rites of the victim according to the directives set by the central and state governments for patients who die of the virus, another senior official said.

"Family members will not be allowed to touch the body since the man had been suffering from cough and breathlessness. Those performing his last rites will be given protective gear, masks and gloves. Though test results are yet to be known, we do not want to take any chance," he said.

Meanwhile, the state health department has issued a directive to all private medical facilities to create a system for assessing all patients at admission allowing early recognition of possible COVID-19 infection and immediate isolation of patients with suspected novel coronavirus infection in an area separate from other patients.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 5,2020

New Delhi, Apr 5: Joining efforts to fight COVID-19, the Defence Research and Development Organisation (DRDO) has designed a full-body disinfection chamber and a special face protection mask for healthcare professionals, officials said.

The special chamber called 'PSE' has been designed by Vehicle Research Development Establishment (VRDE), Ahmednagar, a DRDO Laboratory.

The walk through enclosure is designed for personnel decontamination, one person at a time. It is a portable system equipped with sanitiser and soap dispenser, officials said.

The decontamination is started using a foot pedal at the entry. On entering the chamber, electrically-operated pump creates a disinfectant mist of hypo sodium chloride for disinfecting, the DRDO said in a statement.

The mist spray is calibrated for an operation of 25 seconds and stops automatically indicating completion of operation. As per procedure, personnel undergoing disinfection will need to keep their eyes closed while inside the chamber, it said.

The system consists of roof mounted and bottom tanks with a total of 700 litres capacity. Approximately 650 personnel can pass through the chamber for disinfection until the refill is required, the DRDO said.

The system has see-through glass panels on side walls for monitoring purpose and is fitted with lights for illumination during night-time operations, it added.

This system can be used for disinfection of personnel at the areas of controlled ingress and egress such as entry and exit to hospitals, malls, office buildings and critical installations, officials said.

Also, Research Centre Imarat (RCI), Hyderabad, and Terminal Ballistics Research Laboratory (TBRL), Chandigarh, have developed face protection mask for healthcare professionals handling COVID-19 patients, the DRDO added.

Its light weight construction makes it convenient for comfortable wear for long duration. This design uses commonly available A4 size Over-Head Projection (OHP) film for face protection, it said.

One thousand face shields are being produced daily in TBRL and provided to Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, it said.

Similarly, 100 are produced at RCI and these have been handed over to Employees' State Insurance Corporation (ESIC), Hyderabad. A demand of 10,000 shields has been received from PGIMER and ESIC hospitals based on successful user trials, the DRDO added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.